SITC Primer at ESMO Immuno-Oncology and Advanced Therapies Congress

Join us at the ESMO Immuno-Oncology & Advanced Therapies Congress 2026, which will take place from 14 to 16 December 2026, onsite in London, United Kingdom, and online.

A leading multidisciplinary forum for the global immuno-oncology community, this international meeting will bring together researchers, clinicians and other stakeholders to expand the frontiers of immuno-oncology through advanced therapies, with a strong focus on addressing the current scientific and clinical barriers to effective cancer immunotherapy.

The half-day primer program will cover a wide range of clinical and translational topics across the field of IO. Program information shown below. 

Session Chairs: 

•  Emanuela Romano, MD, PhD, Institut Curie
• Ahmad Tarhini, MD PhD, Moffitt Cancer Center 

Primer Program Agenda 

• Talk 1: Precision immunotherapy of cancer: Biomarkers of clinical benefits and toxicity risks 
  
  • Ahmad Tarhini, MD PhD, Moffitt Cancer Center 
• Talk 2: Neoantigen-based cancer immunotherapy 
  • Patrick Alexander Ott, MD, PhD, Dana-Farber Cancer Institute
• Talk 3: State of the field cellular therapy of solid tumors 
  • Ulrike Köhl, PhD, University of Leipzig
• Talk 4: Myeloid cells in cancer 
  • Emanuela Romano, MD, PhD, Institut Curie
• Talk 5: Complementary single-cell and spatial biology analyses (underlying methodologies)
  • James Wilmott, PhD, Melanoma Institute Australia
• Talk 6: The potential for AI in immuno-oncology drug development 
  • Joe Yeong, PhD, MD, Singapore General Hospital

This program is jointly provided by the Society for Immunotherapy of Cancer (SITC) and the European Society for Medical Oncology (ESMO).